WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2019

Feb 21, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2019-02-19

Reporting Person: Favorite Annette F (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-19	Common Stock	A	863.00	$102.51	Acquired	8267.9617	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-19	Stock Options (Right to buy)	$102.51	A	8160.00	Acquired	2029-02-19	Common Stock (8160.00)	Direct

Footnotes

F1: 2016 PSUs (PP15) award vesting.

F2: This award vests in four equal annual installments beginning on February 19, 2020.